参考文献/References:
[1] Scrocchi LA,Brown TJ,Maclusky N, et al.Glucose intolerance but normal satiety in mice with a null mutation in the glucagon-like peptide 1 receptor gene[J].Nat Med,1996,2(11):1254-1258.
[2] Li Y,Hansotia T,Yusta B,et al.Glucagon-like peptide-1 receptor signaling modulates beta cell apoptosis[J].J Biol Chem,2003,278(1):471-478.
[3] Hansotia T,Maida A,Flock G, et al.Extrapancreatic incretin receptors modulate glucose homeostasis, body weight, and energy expenditure[J].J Clin Invest,2007,117(1):143-152.
[4] Yusta B,Baggio LL,Estall JL, et al.GLP-1 receptor activation improves beta cell function and survival following induction of endoplasmic reticulum stress[J].Cell Metab,2006,4(5):391-406.
[5] Elbr?nd B,Jakobsen G,Larsen S, et al.Pharmacokinetics, pharmacodynamics,safety,and tolerability of a single-dose of NN2211,a long-acting glucagon-like peptide 1 derivative,in healthy male subjects[J].Diabetes Care,2002,25(8):1398-1404.
[6] Wang M,Kipnes M,Matheson S, et al.Safety and pharmacodynamics of CJC-1134-PC,a novel GLP-1 receptor agonist,in patients with type 2 diabetes mellitus:a randomized,Placebo-Controlled; Double-Blind,Dose-Escalation study[J].Diabetes,2007,56(Supp1 1):A133.
[7] Baggio LL,Huang Q,Cao X, et al.An albumin-exendin-4 conjugate engages central and peripheral circuits regulating murine energy and glucose homeostasis[J].Gastroenterology,2008,134(4):1137-1147.
[8] Drucker DJ.Dipeptidyl peptidase-4 inhibition and the treatment of type 2 diabetes: preclinical biology and mechanisms of action[J].Diabetes Care,2007,30(6):1335-1343.
[9] Hansotia T,Baggio LL,Delmeire D, et al.Double incretin receptor knockout(DIRKO)mice reveal an essential role for the enteroinsular axis in transducing the glucoregulatory actions of DPP-Ⅳ inhibitors[J].Diabetes,2004,53(5):1326-1335.
[10] Ussher JR,Drucker DJ.Cardiovascular biology of the incretin system[J].Endocr Rev,2012,33(2):187-215.
[11] Noyan-Ashraf MH,Momen MA,Ban K, et al.GLP-1R agonist liraglutide activates cytoprotective pathways and improves outcomes after experimental myocardial infarction in mice[J].Diabetes,2009,58(4):975-983.
[12] Kim M,Platt MJ,Shibasaki T, et al.GLP-1 receptor activation and Epac2 Link atrial natriuretic peptide secretion to control of blood pressure[J].Nat Med,2013,19(5):567-575.
[13] Ussher JR,Baggio LL,Campbell JE, et al.Inactivation of the cardiomyocyte glucagon-like peptide-1 receptor(GLP-1R)unmasks cardiomyocyte-independent GLP-1R-mediated cardioprotection[J].Mol Metab,2014,3(5):507-517.
[14] Drucker DJ,Erlich P,Asa SL, et al.Induction of intestinal epithelial proliferation by glucagon-like peptide 2[J].Proc Natl Acad Sci U S A,1996,93(15):7911-7916.
[15] Drucker DJ,Shi Q,Crivici A, et al.Regulation of the biological activity of glucagon-like peptide 2 in vivo by dipeptidyl peptidase Ⅳ[J].Nat Biotechnol,1997,15(7):673-677.
相似文献/References:
[1]郑少雄.罗格列酮和心血管风险——近期文献解读[J].国际内分泌代谢杂志,2007,(04):231.
[2]凌厉,朱本章.胰岛素类似物安全性研究进展[J].国际内分泌代谢杂志,2007,(04):234.
[3]李颖,刘东方.餐后1小时血糖升高的意义及干预[J].国际内分泌代谢杂志,2007,(04):235.
[4]崔巍,施秉银.内质网应激介导β细胞生存/死亡的研究进展[J].国际内分泌代谢杂志,2007,(04):256.
[5]杨叶虹,胡仁明.SELDI-TOF-MS技术及其在糖尿病研究中的应用[J].国际内分泌代谢杂志,2007,(04):261.
[6]高妍.针对华人糖尿病特点优化降糖方案[J].国际内分泌代谢杂志,2007,(04):269.
[7]杨志霞,郭莹辉,杨永生,等.胰岛素泵和多次皮下注射治疗糖尿病的比较[J].国际内分泌代谢杂志,2007,(04):273.
[8]周建英,马向华.胃旁路术减肥同时改善糖代谢的机制[J].国际内分泌代谢杂志,2007,(04):285.
[9]袁捷 姜云生 杜彦丽 王肃.1型糖尿病对小鼠早孕时期子宫肌层结构和细胞增殖的影响[J].国际内分泌代谢杂志,2015,(01):6.[doi:10.3760/cma.j.issn.1673-4157.2015.01.002]
Yuan JieJiang YunshengDu YanliWang Su.Effects of type 1 diabetes on the muscularis structure and cell proliferation of uterine in mice during early pregnancy[J].International Journal of Endocrinology and Metabolism,2015,(06):6.[doi:10.3760/cma.j.issn.1673-4157.2015.01.002]
[10]孙艺菡 杨星林 李峰 宋丽娟.幽门螺杆菌感染与糖尿病血管病变[J].国际内分泌代谢杂志,2015,(01):38.[doi:DOI：10.3760/cma.j.issn.1673-4157.2015.01.009]
Sun Yihan,Yang Xinglin,Li Feng,et al.Relationship between Helicobacter pylori infection and diabetic vasculopathy[J].International Journal of Endocrinology and Metabolism,2015,(06):38.[doi:DOI：10.3760/cma.j.issn.1673-4157.2015.01.009]